Events

MaRS Centre, Toronto

Hosted by:

On June 22, 2010, the Ontario Genomics Institute (OGI) Science with Industry workshop program and MaRS Future of Medicine series joined forces to present a one-day workshop on molecular diagnostics.  Dx2010 Markers to Market brought together leading international researchers, regulatory representatives and entrepreneurs from the diagnostics sector to examine regulatory hurdles and commercialization challenges on the path from biomarker discovery to market for molecular diagnostics and prognostics.

Speakers at the event included:

• Greg Hines, CEO, ArcticDX
• Elizabeth Mansfield, Director of Personalized Medicine, FDA
• Thomas Metcalfe, Head, Science and Technology Incubator, Translational Research Sciences (TRS), Roche
• Allen Roses, Director of Deane Drug Discovery Institute, Duke University
• Patrice Sarrazin, Senior Scientific Evaluator, Health Canada
• Lisette Stork-Sloots, Senior Program Director, Agendia

The 70 workshop participants represented academic, investment and commercial institutions active in the diagnostic discovery and product development sector of life sciences, and included researchers, entrepreneurs, intellectual property experts, and venture capital investors.

PRESENTATIONS:

Some of the speakers have made their presentations available.  To view, click on the name below:
- Elizabeth Mansfield, Director of Personalized Medicine, FDA
- Thomas Metcalfe Head, Science and Technology Incubator, Translational Research Sciences, Roche
- Patrice Sarrazin, Senior Scientific Evaluator, Health Canada
- Lisette Stork-Sloots, Senior Program Director, Agendia

INTERVIEWS WITH SPEAKERS:
To view interviews with the speakers, click on the name below:

- Greg Hines, CEO, ArcticDX
- Elizabeth Mansfield, Director of Personalized Medicine, FDA
- Thomas Metcalfe, Head, Science & Technology Incubator, Translational Research Sciences, Roche
- Allen Roses, Director of Deane Drug Discovery Institute, Duke University
- Patrice Sarrazin, Senior Scientific Evaluator, Health Canada
- Lisette Stork-Sloots, Senior Program Director, Agendia 

INTERVIEW WITH OGI's PRESIDENT & CEO:
- Christian Burks, President & CEO, OGI

 INTERVIEWS WITH ATTENDEES:
We spoke to a number of the people attending the workshop to ask their opinions about personalized medicine and diagnostics.  To view the short interviews, click on the names below:

- Jeremy Bridge-Cook, Senior Vice President, Assay Group, Luminex Molecular Diagnostics
- Jung-Kay Chiu, Partner & Patent Agenct, Ogilvy Renault 
- John Connolly, Managing Director, York MedTech Partners
- Philippa Flint, Research Analysist, Bloom Burton & Co.
- Gailina Liew, President & Chief Operating Officer, GeneNews
- Vigen Nazarian, Strategic Alliances and Co-founder, Amorfix 
- Richard Strafehl, CEO Safeguard Biosystems